← All trials
NCT01423838
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2011
- Primary completion
- Sep 1, 2012
- Completion date
- Sep 1, 2012
- First posted
- —
- Last posted
- —
- Enrollment
- 500
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Adana Numune Training and Research HospitalLead sponsor
- Kocaeli UniversityCollaborator
- Akdeniz UniversityCollaborator
- Cukurova UniversityCollaborator
- Baskent UniversityCollaborator
- Inonu UniversityCollaborator
- Kahramanmaras Sutcu Imam UniversityCollaborator
- University of AnkaraCollaborator
- Gaziantep UniversityCollaborator
- Gaziosmanpasa UniversityCollaborator
- Adana Numune Training and Research HospitalReponsible party - principal investigator
- Adana Numune Training and Research HospitalStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.